Sharma, Priyanka
4 papers on CoChatORCID 0000-0001-8592-2239
Most cited papers
- Verified
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Swain, S. M., Miles, D., Kim, S.-B., Im, Y.-H., Im, S.-A., Semiglazov, V., Ciruelos, E., Schneeweiss, A., Loi, S., Monturus, E., et al. (2020) · The Lancet Oncology
HER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes
Cited by 922
- Verified
Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
Rebbeck, T. R., Mitra, N., Wan, F., Sinilnikova, O. M., Healey, S., McGuffog, L., Mazoyer, S., Chenevix-Trench, G., Easton, D. F., Antoniou, A. C., et al. (2015) · JAMA
BRCA gene mutations in cancerMultiple and Secondary Primary Cancers
Cited by 521
- Verified
Biology and Management of Patients With Triple-Negative Breast Cancer
Sharma, P. (2016) · The Oncologist
Breast Cancer Treatment StudiesBRCA gene mutations in cancer
Cited by 294
- Verified
Results of randomized phase II trial of neoadjuvant carboplatin plus docetaxel or carboplatin plus paclitaxel followed by AC in stage I-III triple-negative breast cancer (NCT02413320).
Sharma, P., Kimler, B. F., O'Dea, A., Nye, L. E., Wang, Y. Y., Yoder, R., Prochaska, L. H., Wagner, J. L., Amin, A. L., Larson, K., et al. (2019) · Journal of Clinical Oncology
Breast Cancer Treatment StudiesCancer Treatment and Pharmacology
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free